ARS Pharmaceuticals Overview
ARS Pharmaceuticals Target Price
Analysts' 12-month price predictions for SPRY.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.75
Average Target Price
$25.50
191.4% upside
191.4% upside2 analysts in the last 4 months
High: $26 | Low: $25
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-09 | Northland Securities | $25 | 185.7% upside |  |
| 2026-03-10 | Leerink PartnersRoanna Ruiz | $26 | 197.1% upside | |
| 2025-11-04 | Roth CapitalKyle Bauser | $30 | 242.9% upside | |
| 2025-09-26 | Raymond James | $32 | 265.7% upside | |
| 2024-08-19 | Cantor FitzgeraldJosh Schimmer | $30 | 242.9% upside | |
| 2024-08-12 | Raymond JamesStrong Buy | $22 | 151.4% upside | |
| 2024-07-25 | Raymond JamesRyan Deschner | $18 | 105.7% upside | |
| 2024-03-05 | Leerink PartnersRoanna Ruiz | $18 | 105.7% upside | |
| 2022-12-13 | Leerink Partners | $14 | 60% upside | |